CD274 and digestive system neoplasm: Therefore, we infer that the threshold of tumor diameter maintained at < 20% increase will provide a potential imaging biomarker of whether patients with advanced gastrointestinal tumors should continue treatment with PD-1/PD-L1 inhibitors, which is expected to play an important role in clinical decision-making.